Sign up to save your podcasts
Or
Share Under the microscope: Regeneus (ASX:RGS) - Iain Wilkie, Analyst
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Under the microscope: Regeneus (ASX:RGS) - Iain Wilkie, Analyst
Morgans Analyst Iain Wilkie talks to CEO of ASX listed regenerative medicine and stem-cell player Regeneus (ASX:RGS) on what the company does and a number of potential catalysts which lie ahead.
View all episodes
By Morgans Financial LimitedMorgans Analyst Iain Wilkie talks to CEO of ASX listed regenerative medicine and stem-cell player Regeneus (ASX:RGS) on what the company does and a number of potential catalysts which lie ahead.